drugset / Trial / NCT01977768

TB Immunotherapy Trial With Heat-killed M. Vaccae

NCT01977768 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to carry out multi-country (Ukraine and Mongolia), placebo-controlled, randomized Phase III trial in patients with drug-sensitive, multi-drug resistant (MDR-TB) and TB-HIV and identify efficacy and safety of whole-cell, heat-killed Mycobacterium vaccae formulated as a pill (V7) and consequently conduct confirmatory trials in intended registration countries, such as China, Russia and South Africa, etc.

Timeline

Start
2014-03
Primary completion
2018-10
Completion
2018-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject V7 Vaccine 10 ug Oral

Indications